Adaptive Biotechnologies Corporation
ADPT
$19.66
-$0.06-0.30%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.26% | 43.17% | 34.01% | 29.16% | 0.32% |
| Total Depreciation and Amortization | -10.47% | -14.50% | -14.75% | -13.38% | -8.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.53% | -41.61% | -31.76% | -32.65% | 32.46% |
| Change in Net Operating Assets | -117.59% | -6.02% | 27.25% | 62.21% | 54.81% |
| Cash from Operations | 44.80% | 37.75% | 37.03% | 39.09% | 31.21% |
| Capital Expenditure | 50.78% | 68.04% | 63.25% | 65.75% | 59.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.92% | -32.61% | -48.31% | -41.96% | 56.14% |
| Cash from Investing | 16.03% | -29.36% | -47.06% | -40.00% | 103.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,313.93% | 3,960.67% | 249.29% | -89.27% | -91.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,313.93% | 3,960.67% | 249.29% | -89.27% | -90.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.95% | 65.73% | 8.32% | 29.69% | 60.60% |